Most cases of prostate cancer are revealed using digital rectal examination, by diagnostic tests to determine prostate-specific antigen (PSA) levels, transrectal ultrasound (TRUS), and multiparametric MRI, while diagnosis is confirmed by tissue analysis obtained on image-guided transrectal biopsy. The gene discussed is KLK3; the disease is prostate cancer.